La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Doximity Gestione
Gestione criteri di controllo 3/4
Doximity's Il CEO è Jeff Tangney, nominato in Apr2010, e ha un mandato di 14.33 anni. la retribuzione annua totale è $ 298.87K, composta da 98.7% di stipendio e 1.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 27.35% delle azioni della società, per un valore di $ 1.82B. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.5 anni e 8.9 anni.
Informazioni chiave
Jeff Tangney
Amministratore delegato
US$298.9k
Compenso totale
| Percentuale dello stipendio del CEO | 98.7% |
| Mandato del CEO | 14.4yrs |
| Proprietà del CEO | 27.3% |
| Durata media del management | 3.6yrs |
| Durata media del Consiglio di amministrazione | 9yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors
Sep 23
There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump
Aug 18Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns
Aug 10Doximity Faces Slower Revenue Growth As R&D Costs May Rise
Jul 23Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?
Jul 23At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?
Jul 01Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking
Jun 09Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)
May 17Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal
May 04Doximity: Significant Upside Remains, But Not Until The Growth Story Returns
Apr 29With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For
Apr 16Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Mar 26Doximity: Rating Upgrade To Buy As Outlook Turns Positive
Feb 21We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit
Feb 15What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?
Feb 13Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan
Jan 16Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital
Jan 04Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price
Dec 14Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism
Nov 10Doximity: Adding Value Using AI But Faces Near-Term Risks
Nov 01Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 30Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively
Sep 25Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook
Aug 24Doximity Earnings: Too Many Problems, Sell
Aug 09A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)
Jul 29Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching
Jul 09Doximity: Continue To See Positive Upside From Current Stock Level
Jul 05The Returns At Doximity (NYSE:DOCS) Aren't Growing
Jun 21Doximity: Digital Health Play With Strong Fundamentals
Jun 21A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Apr 07Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return
Mar 20Doximity: Good Business But Extremely Overvalued
Feb 18Doximity Q3 Earnings: Disappointing Results
Feb 10Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Dec 25Doximity: On The Right Path To Further Consolidate Market Share
Dec 22Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital
Dec 04Doximity up 16% after fiscal 2023 Q2 beats, FY revenue range includes consensus
Nov 10Doximity, down 9%, falls below IPO price
Oct 12Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$161m |
| Mar 31 2024 | US$299k | US$295k | US$148m |
| Dec 31 2023 | n/a | n/a | US$138m |
| Sep 30 2023 | n/a | n/a | US$123m |
| Jun 30 2023 | n/a | n/a | US$119m |
| Mar 31 2023 | US$244k | US$240k | US$113m |
| Dec 31 2022 | n/a | n/a | US$119m |
| Sep 30 2022 | n/a | n/a | US$141m |
| Jun 30 2022 | n/a | n/a | US$148m |
| Mar 31 2022 | US$243k | US$240k | US$133m |
| Dec 31 2021 | n/a | n/a | US$107m |
| Sep 30 2021 | n/a | n/a | US$57m |
| Jun 30 2021 | n/a | n/a | US$30m |
| Mar 31 2021 | US$21m | US$240k | US$22m |
Compensazione vs Mercato: La retribuzione totale di Jeff ($USD 298.87K ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 8.39M ).
Compensazione vs guadagni: La retribuzione di Jeff è aumentata di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Jeff Tangney (51 yo)
14.4yrs
Mandato
US$298,869
Compensazione
Mr. Jeffrey A. Tangney, also known as Jeff, Co-Founded Doximity, Inc. in 2010 and has been its Chief Executive Officer and Director since April 2010 and serves as its Chairperson. Mr. Tangney also serves a...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 14.4yrs | US$298.87k | 27.35% $ 2.2b | |
| Co-Founder & Chief Strategy Officer | no data | US$305.47k | 0.26% $ 20.7m | |
| Chief Financial Officer | 3.6yrs | US$3.87m | 0.12% $ 9.7m | |
| General Counsel & Corporate Secretary | 4.1yrs | US$603.94k | 0.0032% $ 253.3k | |
| Senior Vice President of Commercial Operations | 1.3yrs | US$5.21m | 0.012% $ 916.8k | |
| Co-founder and SVP People & Ops | no data | Nessun dato | Nessun dato | |
| Chief Technology Officer | no data | Nessun dato | Nessun dato | |
| Head of Investor Relations | no data | Nessun dato | Nessun dato | |
| Head of Corporate Communications | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Engineering | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Product | no data | Nessun dato | Nessun dato | |
| Senior VP & GM Commercial Products | 1.3yrs | Nessun dato | Nessun dato |
3.6yrs
Durata media
45.5yo
Età media
Gestione esperta: Il team dirigenziale di DOCS è considerato esperto (durata media dell'incarico 3.5 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 14.4yrs | US$298.87k | 27.35% $ 2.2b | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 4yrs | US$239.94k | 0.0025% $ 202.3k | |
| Independent Director | 13.5yrs | US$241.94k | 0.13% $ 10.5m | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 4.5yrs | US$233.94k | 0.0055% $ 440.5k |
9.0yrs
Durata media
51.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di DOCS sono considerati esperti (durata media dell'incarico 8.9 anni).